Evidence map›Paper›PMID 36294574›Full record

ArticleJournal of fungi (Basel, Switzerland)2022

The Drug H

Tianling Ma, Yiqing Li, Yang Lou, Junrui Shi, Kewei Sun, Zhonghua Ma, Leiyan Yan, Yanni Yin

Open access · goldAbstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. The Dual PathogenJournal of fungi (Basel, Switzerland) · 2025
    Review
  6. The Mechanisms of Developing Fungicide Resistance inPathogens (Basel, Switzerland) · 2024
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Tianling MaState Key Laboratory of Rice Biology, Institute of Biotechnology, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China.
Yiqing LiState Key Laboratory of Rice Biology, Institute of Biotechnology, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China.
Yang LouState Key Laboratory of Rice Biology, Institute of Biotechnology, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China.
Junrui ShiState Key Laboratory of Rice Biology, Institute of Biotechnology, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China.
Kewei SunState Key Laboratory of Rice Biology, Institute of Biotechnology, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China.
Zhonghua MaState Key Laboratory of Rice Biology, Institute of Biotechnology, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China.ORCID 0000-0002-5426-0997
Leiyan YanNingbo Academy of Agricultural Sciences, Ningbo 315040, China.
Yanni YinState Key Laboratory of Rice Biology, Institute of Biotechnology, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China.ORCID 0000-0002-0798-3420
China National Rice Research Institute · CNNingbo Academy of Agricultural Sciences · CNZhejiang A & F University · CN

Funding

China Agriculture Research System CARS-3-1-29Fundamental Research Funds for the Central Universities 2021FZZX001-31National Natural Science Foundation of China 31871910National Science Foundation of China 32072449Special Fund for Public Projects of Zhejiang Province LZ22C140003the Key Project of National Natural Science Foundation of China 31930088
6 · The paper itself

Abstract

Increased emergence of drug resistance and DON pollution pose a severe problem in Fusarium head blight (FHB) control. While the H

Indexed as

Fusarium head blightH+ antiporter (DHA)multiple drug resistancevirulence

Identifiers

PMID36294574
PMCPMC9605015
OpenAlexW4297541623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.